[{"Assets_0_Q1_USD":3952769000.0,"EarningsPerShareBasic_1_Q1_USD":0.42,"EarningsPerShareDiluted_1_Q1_USD":0.41,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-56220000.0,"NetIncomeLoss_1_Q1_USD":12413000.0,"StockholdersEquity_0_Q1_USD":2707466000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":29911000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":29580000.0,"Ticker":"BIO","CIK":"12208","name":"BIO RAD LABORATORIES INC","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20170509"}]